Are Scare Tactics Being Used to Avoid Biosimilar Competition?

According to U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, less than two percent of Americans use biologics, but they account for 40 percent of total spending on prescription drugs.